CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoLOLLI, Marco Lucio
Pubblicazioni
Risultati 1 - 20 di 93 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | 1,2,5-Oxadiazole analogues of leflunomide and related compounds | 2011 | Marta Giorgis; Marco Lucio Lolli; Barbara Rolando; Angela Rao; Paolo Tosco; Shilpi Chaurasia; Domenica Marabello; Roberta Fruttero; Alberto Gasco. |
| 2 | 1H-pyrazole-4-carboxylic acids active against Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH): discovery of a new scaffold for development of antimalarial agents | 2014 | Agnese Chiara Pippione; Ulf J. Nilsson; Ingela Fritzson; Anders P. Sundin; Salam Al-Karadaghi; Donatella Boschi; and Marco Lucio Lolli |
| 3 | 4-Hydroxy-1,2,3-triazole moiety as bioisostere of the carboxylic acid function: a novel scaffold to probe the orthosteric γ-aminobutyric acid receptor binding site | 2018 | Giraudo, Alessandro; Krall, Jacob; Nielsen, Birgitte; Sørensen, Troels E.; Kongstad, Kenneth T.; Rolando, Barbara; Boschi, Donatella; Frølund, Bente; Lolli, Marco L. |
| 4 | 4-Hydroxy-1,2,5-oxadiazol-3-yl Moiety as Bioisoster of the Carboxy Function. Synthesis, Ionization Constants, and Molecular Pharmacological Characterization at Ionotropic Glutamate Receptors of Compounds Related to Glutamate and Its Homologues | 2010 | Marco L. Lolli; Cecilia Giordano; Darryl S. Pickering; Barbara Rolando; Kasper B. Hansen; Antonio Foti; Alberto Contreras-Sanz; Ahmad Amir; Roberta Fruttero; Alberto Gasco; Birgitte Nielsen; Tommy N. Johansen |
| 5 | 4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade | 2017 | Pippione, Agnese C.; Federico, Antonella; Ducime, Alex; Sainas, Stefano; Boschi, Donatella; Barge, Alessandro; Lupino, Elisa; Piccinini, Marco; Kubbutat, Michael; Contreras, Jean-Marie; Morice, Christophe; Al-Karadaghi, Salam; Lolli, Marco L. |
| 6 | A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action | 2017 | Campaner, Elena; Rustighi, Alessandra; Zannini, Alessandro; Cristiani, Alberto; Piazza, Silvano; Ciani, Yari; Kalid, Ori; Golan, Gali; Baloglu, Erkan; Shacham, Sharon; Valsasina, Barbara; Cucchi, Ulisse; Pippione, Agnese Chiara; Lolli, Marco Lucio; Giabbai, Barbara; Storici, Paola; Carloni, Paolo; Rossetti, Giulia; Benvenuti, Federica; Bello, Ezia; D'Incalci, Maurizio; Cappuzzello, Elisa; Rosato, Antonio; Del Sal, Giannino |
| 7 | A new class of ibuprofen derivatives with reduced gastrotoxicity | 2001 | L. LOLLI; C. CENA; C. MEDANA; L. LAZZARATO; G. MORINI; G. CORUZZI; S. MANARINI; R. FRUTTERO; A. GASCO |
| 8 | Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for therapeutic intervention | 2017 | Pippione, Agnese C.; Boschi, Donatella; Pors, Klaus; Oliaro-Bosso, Simonetta; Lolli, Marco L. |
| 9 | Antiinflammatory, gastrosparing, and antiplatelet properties of new NO-donor esters of aspirin | 2003 | CENA C; LOLLI ML; LAZZARATO L; GUAITA E; MORINI G; CORUZZI G; MCELROY SP; MEGSON IL; FRUTTERO R; GASCO A |
| 10 | APPLICATION OF THE ARACHNO™ TECHNOLOGY FOR THE PARALLEL SYNTHESIS OF A LIBRARY OF ASPIRIN ANALOGUES | 2015 | Moreo, Angela; Barge, Alessandro; Boschi, Donatella; Costale, Annalisa; Dosio, Franco; Federico, Antonella; Stevanato, Livio; L. Lolli., Marco |
| 11 | Application of the arachno™ technology inside Educational fields: the introduction of parallel synthesis concepts inside an undergraduated lab | 2016 | L. Lolli, Marco; *a, ; Angela Moreo, B; Alessandro Barge, A; Donatella Boschi, A; Annalisa Costale, A; Livio Stevanatoa and Franco Dosioa |
| 12 | Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 | 2019 | Lolli, Marco L; Carnovale, Irene M; Pippione, Agnese C; Wahlgren, Weixiao Y; Bonanni, Davide; Marini, Elisabetta; Zonari, Daniele; Gallicchio, Margherita; Boscaro, Valentina; Goyal, Parveen; Friemann, Rosmarie; Rolando, Barbara; Bagnati, Renzo; Adinolfi, Salvatore; Oliaro-Bosso, Simonetta; Boschi, Donatella |
| 13 | Design, synthesis, and biological evaluation of flufenamic acid derived bioisosteres as inhibitors of aldo-keto reductase 1C3 (AKR1C3) expressed in prostate cancer | 2016 | Lolli, Marco; Cena, Clara; Giraudo, Alessandro; Marini, Elisabetta; Pippione, Agnese; Oliaro-Bosso, Simonetta; Ferrante, Terenzio; Sadiq, Maria; Pors, Klaus; Boschi, Donatella; Braga, Rudolpho; Andrade, Carolina. |
| 14 | Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds | 2017 | Sainas, Stefano; Pippione, Agnese C.; Giorgis, Marta; Lupino, Elisa; Goyal, Parveen; Ramondetti, Cristina; Buccinnà, Barbara; Piccinini, Marco; Braga, Rodolpho C.; Andrade, Carolina H.; Andersson, Mikael; Moritzer, Ann-Christin; Friemann, Rosmarie; Mensa, Stefano; Al-Kadaraghi, Salam; Boschi, Donatella; Lolli, Marco L |
| 15 | Detection of O6-Butylguanine and O6-(4-Hydroxybutyl)guanine in Urothelial and Hepatic DNA of Rats Given the Bladder Cancerogen N-Nitrosobutyl-(4-hydroxybutyl)amine | 1994 | AIROLDI L; MAGAGNOTTI C; BONFANTI M; CHIAPPETTA L; M. LOLLI; MEDANA C; DE GREGARIO G. AND FANELLI R |
| 16 | Development of new hydroxypyrazole-based inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) | 2014 | A.C. Pippione; A. Giraudo; I. Galleano; U.J. Nilsson; I. Fritzson; A.P. Sundin; S. Al-Karadaghi; D. Boschi; M.L. Lolli |
| 17 | Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation | 2018 | Stefano Sainas, Agnese C. Pippione, Davide Bonanni, Marta Giorgis, Elisa Lupino, Enrico Giraudo, Paola Circosta, Valentina Gaidano, Alessandro Cignetti, Marco Piccinini, Giuseppe Saglio, Salam Al-Karadaghi, Donatella Boschi, Marco L. Lolli |
| 18 | DHODH inhibitors and leukemia: an emergent interest for new myeloid differentiation agents | 2018 | Sainas, S; Pippione, AC; Boschi, D; Gaidano, V; Circosta, P; Cignetti, A; Dosio, F; Lolli, ML |
| 19 | A differentiating and apoptotic therapy for acute myeloid leukaemia using potent human dihydroorotate dehydrogenase inhibitors. | 2019 | Stefano Sainas, Agnese Chiara Pippione, Davide Bonanni, Marta Giorgis, Paola Circosta, Marilena Marraudino, Valentina Gaidano, Alessandro Cignetti, Giuseppe Saglio, Salam Al-Karadaghi, Donatella Boschi, Marco Lucio Lolli |
| 20 | Discovery and optimization of new OvCHT1 inhibitors based on the 4-hydroxy-1H-1,2,3-triazole ring | 2014 | A. Ducime; A. C. Pippione; A. Moreo; A. Piccinelli; M. Gooyit; K. D. Janda; D. Boschi; M. L. Lolli |
Dettaglio
LOLLI, Marco Lucio
SCIENZA E TECNOLOGIA DEL FARMACO
Copyright © 2020